trial · primary record
JX09 or placebo SAD
Resistant Hypertension
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 92 |
| Primary completion | 2024-12-31 |
| Primary endpoint | The incidence of adverse events and serious adverse events in health subjects. |
| Registry ID | NCT06183671 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:49.603Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06183671
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.